Holocene Advisors, LP Madrigal Pharmaceuticals, Inc. Transaction History
Holocene Advisors, LP
- $31.7 Billion
- Q1 2025
A detailed history of Holocene Advisors, LP transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Holocene Advisors, LP holds 390,545 shares of MDGL stock, worth $107 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
390,545Holding current value
$107 Million% of portfolio
0.41%Shares
1 transactions
Others Institutions Holding MDGL
# of Institutions
367Shares Held
23.3MCall Options Held
979KPut Options Held
459K-
Janus Henderson Group PLC London, X02.21MShares$605 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$575 Million39.89% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$554 Million10.84% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$546 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$541 Million7.8% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $4.69B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...